Perspectives

All Case Studies Views Resources Whitepapers Podcasts On-Demand Webinars
Using Real-World Data in the Health Technology Assessment of Pharmaceuticals
n a five article series published in leading health economics and outcomes research (HEOR) journal, Value in Health, Lumanity HEOR Executive Chair, Ron Akehurst, and Senior Director, Linda Murphy, collaborate with other industry experts to identify obstacles to the optimal use of RWE in HTA, and also present detailed solutions.
View Apr 20, 2023
Facing Up to the Challenges of EU Joint Clinical Assessments
Joint Clinical Assessment is central to the success of the European Union Health Technology Assessment (EU HTA) Regulation but there are challenges ahead for the oncology, rare disease and advanced therapy medicinal product sectors.
Whitepaper Mar 31, 2023